Research Guide · Annotated Bibliography

Annotated Bibliography

Every specific, named claim on this site — a GAO audit, a JAMA study, a CDC report — traces to a real source. This page collects them in one place: the full citation, a link to read it yourself, a plain-language note on what it actually shows, and which page or book cites it. Built as a resource for researchers, journalists, and readers who want to check the work, not just take our word for it.

Every entry below was independently verified against the primary source — not just checked for a working link, but read to confirm it actually says what it's cited for. Where our own research surfaced a mismatch between a claim and its source, we corrected the claim on the page in question rather than publish a citation that doesn't hold up; see How We Source Claims. This bibliography currently covers the sourced claims already published across the site and will grow as new investigations are added.

Filters the Topics below as you type — no ‘Enter’ needed.

Topic

Prescription Drug Pricing & PBMs

The evidence behind Before the Counter and the Prescription Drugs research guide.

Government Report

Prescription Drugs: VA Paid About Half as Much as Medicare Part D for Selected Drugs in 2017

U.S. Government Accountability Office, GAO-21-111 · December 2020

Comparing prices for 399 matched brand-name and generic drugs, GAO found the VA paid on average 54% less per unit than Medicare Part D in 2017, even after accounting for Part D rebates and discounts.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Government Report

Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs

Federal Trade Commission, Interim Staff Report · July 2024

The FTC found the three largest PBMs — CVS Caremark, Express Scripts, and OptumRx — managed 79% of U.S. prescription drug claims in 2023, up from 70% in 2016, each owned by the same corporate family as a major health insurer.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Peer-Reviewed Study

Assessment of Spending in Medicare Part D If Medication Prices From the VA Were Used

Venker, Stephenson & Gellad · JAMA Internal Medicine, 2019

This research letter found Medicare Part D spent $32.5 billion on the top 50 oral drugs in 2016; at VA prices, the same drugs would have cost $18.0 billion — a $14.4 billion gap.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Research Report

International Prescription Drug Price Comparisons: Estimates Using 2022 Data

RAND Corporation, Report RRA788-3 · February 2024

RAND found U.S. brand-name drug prices ran 3.22 times those of 33 comparison countries, even after accounting for estimated manufacturer rebates.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Peer-Reviewed Study

Contribution of NIH Funding to New Drug Approvals 2010–2016

Cleary, Beierlein, Khanuja, McNamee & Ledley · Proceedings of the National Academy of Sciences, 2018

NIH-funded research was linked to every one of the 210 new drugs the FDA approved between 2010 and 2016, backed by more than $100 billion in NIH project funding over that period.

Cited in: Before the Counter, Prescription Drugs guide, Beyond Reform

Read the source →

Government Report

Additional Information About Drug Price Negotiation and CBO's Simulation Model of Drug Development

Congressional Budget Office · December 21, 2023

CBO estimated that over the next 30 years, 13 fewer new drugs of roughly 1,300 expected will reach the market as a result of Medicare's new negotiating authority — about a 1% reduction.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Government Report

Estimated Budgetary Effects of H.R. 5376, the Inflation Reduction Act of 2022

Congressional Budget Office · August 3, 2022

CBO's official cost estimate projected roughly $101.8 billion in Medicare savings from 2022–2031 from the IRA's drug-negotiation provision — the basis for the commonly cited "$102 billion" figure.

Cited in: Before the Counter, Prescription Drugs guide

Read the source →

Peer-Reviewed Study · Author's Own Research

Cost-Effectiveness of Prospective and Continuous Parenteral Antibiotic Control

Coleman, Rodondi, Kaubisch, Granzella & O'Hanley · The American Journal of Medicine, 1991

Robert Coleman's own published research on VA antibiotic stewardship found prospective review of IV antibiotic orders cut antibiotic costs by about a third with no increase in mortality — the pilot that became the basis of a national Medicare/Medicaid stewardship requirement in 2019.

Cited in: Before the Counter

Read the source →

Topic

Hospital & Insurer Consolidation

The evidence behind Behind the System, the Insurance & Financing research guide, and A Case for Single-Payer Healthcare.

Survey / Research Report

How Health Insurance Coverage Denials Affect Americans

Richards, Collins, Gupta & Roy · The Commonwealth Fund, 2025 Affordability Survey · June 2026

A nationally representative survey found that among people whose care was blocked by prior authorization, 63% reported worry or anxiety, 41% said the denial delayed their care, and 28% said a health problem worsened as a result.

Cited in: Behind the System, Healthcare Financialization guide

Read the source →

Peer-Reviewed Study

Social Determinants of Health and Insurance Claim Denials for Preventive Care

Horný · JAMA Network Open, 2024

A cohort study of more than 1.5 million privately insured patients found Black patients and lower-income patients faced measurably higher denial rates for no-cost preventive care than white and higher-income patients.

Cited in: Behind the System, Healthcare Financialization guide

Read the source →

Peer-Reviewed Study

Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition

Kannan, Bruch & Song · JAMA, 2023

Using Medicare claims data on 662,095 hospitalizations, this study found a 25.4% increase in hospital-acquired conditions — including a 27.3% rise in falls and a 37.7% rise in central-line infections — after private equity acquired a hospital.

Cited in: Behind the System, Healthcare Financialization guide

Read the source →

Systematic Review

Evaluating Trends in Private Equity Ownership and Impacts on Health Outcomes, Costs, and Quality

Borsa, Bejarano, Ellen & Bruch · BMJ, 2023

A systematic review of 55 studies (2000–2023) covering private-equity ownership across hospitals, physician practices, nursing homes, and other healthcare settings found PE ownership was most consistently linked to higher costs — nine of twelve cost-focused studies found increases, none found decreases.

Cited in: Behind the System, Healthcare Financialization guide

Read the source →

Peer-Reviewed Study

Is There a VA Advantage? Evidence from Dually Eligible Veterans

Chan, Card & Taylor · American Economic Review, 2023

Using a natural-experiment design among veterans eligible for both VA and Medicare-financed private hospital care, this study found the VA reduced 28-day mortality by 46% and 28-day spending by 21% relative to comparison hospitals.

Cited in: A Case for Single-Payer Healthcare

Read the source →

Investigative Report

100 Million People in America Are Saddled With Health Care Debt

Levey · KFF Health News, with NPR · June 16, 2022

Drawing on an original KFF poll and Urban Institute/JPMorgan Chase Institute data, this investigation found more than 100 million Americans (41% of adults) carry some form of healthcare debt, driving many into bankruptcy.

Cited in: Behind the System, Healthcare Financialization guide

Read the source →

Topic

Public Trust in Public Health Institutions

The evidence behind Broken Trust and Science Under Siege.

National Poll

One Year In: Public Views of a Changing Public Health Landscape

de Beaumont Foundation & Harvard T.H. Chan School of Public Health · June 2026

A national poll found trust in CDC health recommendations fell from 77% in spring 2025 to 50% a year later — the steepest decline among Democrats (92% to 34%), with a modest rise among Republicans (63% to 67%).

Cited in: Broken Trust, Science Under Siege, homepage

Read the source →

National Poll

100 Days In: Americans' Perceptions, Expectations, and Trust in Public Health

de Beaumont Foundation & Harvard T.H. Chan School of Public Health · 2025

The baseline spring-2025 poll establishing the 77% CDC-trust figure used as the starting point for the one-year comparison above.

Cited in: Broken Trust, Science Under Siege

Read the source →

News Report

CDC Has Shed One-Quarter of Staff Even as It Recalls Some Laid-Off Workers

Government Executive · June 2025

Reports that CDC lost approximately one-quarter of its workforce following HHS's March 2025 restructuring, with roughly 2,400 positions cut in the initial reduction before partial recalls.

Cited in: Science Under Siege, When Science Became Political

Read the source →

News Report

RFK Jr. Removes All Current Members of CDC Vaccine Advisory Committee

CNN · June 9, 2025

Confirms HHS Secretary Robert F. Kennedy Jr. dismissed all 17 sitting members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9, 2025.

Cited in: Science Under Siege, When Science Became Political

Read the source →

Peer-Reviewed Study

How the 2025 NIH Grant Terminations Varied by Researchers' Demographic Groups

Oliveira, Huang, Woodruff & Uzzi · Proceedings of the National Academy of Sciences, 2026

Peer-reviewed analysis confirms NIH terminated 2,291 active research grants between February and August 2025, withdrawing $2.45 billion from the federal research budget.

Cited in: Science Under Siege, When Science Became Political

Read the source →

Topic

Vaccine Policy & Measles (2025–2026)

The evidence behind When Science Became Political.

Government Report

Measles Outbreak — New Mexico, 2025

CDC, Morbidity and Mortality Weekly Report, Vol. 75, No. 9 · March 2026

Official CDC report confirming New Mexico ran 60 mobile MMR vaccination clinics across 11 counties, coinciding with a 55% increase in statewide MMR doses administered, before the 99-case outbreak was declared over in September 2025; it also documents one death, in an unvaccinated adult.

Cited in: When Science Became Political

Read the source →

News Reporting

2025 U.S. Measles Deaths, Including Daisy Hildebrand

CIDRAP and Newsweek reporting · 2025

Combined reporting documents four measles deaths in the U.S. in 2025, three of them children, including 8-year-old Daisy Hildebrand of Lubbock, Texas — unvaccinated, with no underlying conditions.

Cited in: When Science Became Political

Read the source →

Government Reference

Measles Vaccination

Centers for Disease Control and Prevention · reviewed 2026

CDC's standard reference confirming two doses of MMR vaccine are 97% effective against measles (one dose, 93%).

Cited in: When Science Became Political

Read the source →

News Report

Senate Committee Endorses NIH Budget Increase, Rebuking Proposed 40% Cut

STAT News · July 2025 – January 2026

Documents Congress rejecting the administration's proposed roughly 40% cut to NIH funding, ultimately increasing FY26 NIH appropriations.

Cited in: When Science Became Political

Read the source →

Court Ruling

American Academy of Pediatrics et al. v. Kennedy et al.

U.S. District Court, District of Massachusetts, No. 1:25-cv-11916 · March 2026

A federal court found HHS/CDC's narrowing of the universally recommended childhood immunization schedule likely violated the Administrative Procedure Act.

Cited in: When Science Became Political

Read the source →

Professional Endorsement

12 Medical Groups Representing 1 Million Health Care Professionals Endorse AAP Immunization Schedule

AAP News, American Academy of Pediatrics

Confirms twelve medical organizations representing more than a million clinicians formally endorsed the American Academy of Pediatrics' independent 2026 vaccine schedule.

Cited in: When Science Became Political

Read the source →

Data Tracker

State Recommendations for Routine Childhood Vaccines: Increasing Departure from Federal Guidelines

KFF · as of January 2026

KFF tracking confirms 28 states (plus DC) had departed from CDC's revised childhood vaccine recommendations for at least some vaccines as of January 2026.

Cited in: When Science Became Political

Read the source →

Topic

COVID-19 Mortality & Policy Response

The evidence behind Unnecessary Deaths.

Government Data

Excess Deaths Associated with COVID-19

CDC / National Center for Health Statistics, National Vital Statistics System

CDC's official excess-mortality tracker, defining excess deaths as observed deaths minus deaths expected from pre-pandemic trends; the roughly 1.3 million U.S. total cited on this site reflects cumulative excess mortality through 2022.

Cited in: Unnecessary Deaths

Read the source →

Research Report

130,000–210,000 Avoidable COVID-19 Deaths — and Counting — in the U.S.

National Center for Disaster Preparedness, Columbia University Earth Institute (Irwin Redlener) · October 2020

Comparing the actual U.S. COVID-19 death toll through October 2020 to what it would have been had the U.S. matched six peer nations on testing, lockdown timing, and national mask mandates, this report estimated 130,000–210,000 avoidable deaths.

Cited in: Unnecessary Deaths

Read the source →

Government Report

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults, With and Without Booster Doses

CDC, Morbidity and Mortality Weekly Report, 2022

During the Delta-dominant period (October–November 2021), unvaccinated people had 12.7 times the risk of death compared with fully vaccinated people without a booster, and 53.2 times the risk compared with those who had received a booster.

Cited in: Unnecessary Deaths

Read the source →

Peer-Reviewed Study

Higher COVID-19 Vaccination Rates Are Associated with Lower COVID-19 Mortality: A Global Analysis

Adams et al. · Vaccines (MDPI), 2023

Across 164 countries, a 10-percentage-point increase in vaccination coverage was associated with an 18.1% decrease in COVID-19 mortality at six months.

Cited in: Unnecessary Deaths

Read the source →

Found a source that doesn't hold up, or have a citation you'd like added?